BPIRY yields 103.93% · PFE yields 6.13%● Live data
📍 BPIRY pulled ahead of the other in Year 1
Combined, BPIRY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BPIRY + PFE for your $10,000?
Piraeus Financial Holdings S.A. provides banking products and services in Greece and internationally. It operates through Retail Banking, Corporate Banking, Piraeus Financial Markets, and Other segments. The company offers time, structured, deposit, saving, current, and business accounts; mortgage, consumer, personal, home improvement, farming, restructuring, and working capital loans; overdrafts; credit, debit, contract farming, and prepaid cards; mutual funds, treasury bonds, equities, dual currency deposits, treasury interest-bearing notes, asset management solutions, and gold sovereigns and gold bars; and car, home, civil liability, health, endowment, accident/life, lifestyle, agricultural, photovoltaic park, trade credit, business premises, and corporate insurances. It also provides financial planning, payment/remittance, bills of exchange collection, cash management, import-export settlement, payroll, foreign exchange, risk management, letters of guarantee, factoring, leasing, and Web banking services. The company offers infrastructure advisory, project and real estate finance, remote banking service, group life and health and electronic and cyber risks insurance programs, debt collection, and contract farming. It operates 414 branches in Greece and another 16 branches in 2 countries. Piraeus Financial Holdings S.A. was formerly known as Piraeus Bank S.A. The company was founded in 1916 and is based in Athens, Greece.
Full BPIRY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.